Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
264
Top-10 weight
52.88%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
24
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
698.2
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | — | 10,825,717 | $10.83M | 14.29% |
| 2 | GILEAD SCIENCES INC | — | 48,865 | $7.28M | 9.61% |
| 3 | VERTEX PHARMACEUTICALS INC | — | 14,178 | $7.04M | 9.30% |
| 4 | AMGEN INC | — | 17,796 | $6.91M | 9.12% |
| 5 | REGENERON PHARMACEUTICALS INC | — | 5,839 | $4.56M | 6.03% |
| 6 | Invesco Private Government Fund | — | 4,201,477 | $4.20M | 5.55% |
| 7 | ALNYLAM PHARMACEUTICALS INC | — | 7,470 | $2.49M | 3.28% |
| 8 | INSMED INC | — | 12,065 | $1.80M | 2.38% |
| 9 | BIOGEN INC | — | 8,295 | $1.59M | 2.10% |
| 10 | ARGENX SE SPONSORED ADR | — | 1,648 | $1.26M | 1.67% |
| 11 | UNITED THERAPEUTICS CORP DEL | — | 2,437 | $1.23M | 1.62% |
| 12 | MODERNA INC | — | 22,109 | $1.18M | 1.56% |
| 13 | ILLUMINA INC | — | 8,646 | $1.16M | 1.53% |
| 14 | ROIVANT SCIENCES | — | 39,369 | $1.14M | 1.50% |
| 15 | INCYTE CORP | — | 11,115 | $1.13M | 1.49% |
| 16 | ROYALTY PHARMA-A | — | 24,171 | $1.12M | 1.47% |
| 17 | REVOLUTION MEDICINES INC | — | 10,938 | $1.12M | 1.47% |
| 18 | VIATRIS INC | — | 65,178 | $973.11K | 1.28% |
| 19 | Ascendis Pharma A/S | — | 3,474 | $811.18K | 1.07% |
| 20 | NEUROCRINE BIOSCIENCES INC | — | 5,641 | $746.02K | 0.98% |
| 21 | IONIS PHARMACEUTICALS INC | — | 9,163 | $743.58K | 0.98% |
| 22 | SANOFI SPON ADR | SNY US | 14,988 | $729.32K | 0.96% |
| 23 | BRIDGEBIO PHARMA INC | — | 10,918 | $725.83K | 0.96% |
| 24 | MEDPACE HOLDINGS INC | — | 1,593 | $719.65K | 0.95% |
| 25 | SUMMIT THERAPEUTICS INC | — | 42,174 | $699.67K | 0.92% |
| 26 | GUARDANT HEALTH INC | — | 7,319 | $687.25K | 0.91% |
| 27 | BIOMARIN PHARMACEUTICAL INC | — | 10,885 | $671.93K | 0.89% |
| 28 | EXELIXIS INC | — | 15,175 | $668.61K | 0.88% |
| 29 | JAZZ PHARMACEUTI | — | 3,442 | $654.05K | 0.86% |
| 30 | BIONTECH SE ADR | — | 5,726 | $631.18K | 0.83% |
| 31 | BEONE MEDICINES LTD ADR | — | 1,784 | $565.51K | 0.75% |
| 32 | MADRIGAL PHARMACEUTICALS INC | — | 1,287 | $555.98K | 0.73% |
| 33 | IMMUNITYBIO INC | — | 55,881 | $546.52K | 0.72% |
| 34 | TEMPUS AI INC-A | — | 9,809 | $522.33K | 0.69% |
| 35 | ARROWHEAD PHARMACEUTICALS INC | — | 7,676 | $485.66K | 0.64% |
| 36 | PRAXIS PRECISION MEDICINES INC | — | 1,420 | $478.18K | 0.63% |
| 37 | AXSOME THERAPEUTICS INC | — | 2,849 | $466.92K | 0.62% |
| 38 | HALOZYME THERAPEUTICS INC | — | 6,671 | $463.83K | 0.61% |
| 39 | VAXCYTE INC | — | 7,425 | $458.42K | 0.61% |
| 40 | KRYSTAL BIOTECH INC | — | 1,646 | $453.70K | 0.60% |
| 41 | CYTOKINETICS INC | — | 6,884 | $428.32K | 0.57% |
| 42 | NUVALENT INC-A | — | 4,101 | $418.10K | 0.55% |
| 43 | Abivax SA SPONSORED ADS | ABVX US | 3,337 | $404.71K | 0.53% |
| 44 | ARCELLX INC | — | 3,276 | $372.78K | 0.49% |
| 45 | KYMERA THERAPEUTICS INC | — | 4,067 | $371.52K | 0.49% |
| 46 | RHYTHM PHARMACEUTICALS INC | — | 3,774 | $349.96K | 0.46% |
| 47 | COGENT BIOSCIENCES INC | — | 8,738 | $339.47K | 0.45% |
| 48 | PROTAGONIST THERAPEUTICS INC | — | 3,560 | $327.80K | 0.43% |
| 49 | CRISPR Therapeutics A.G. Series A | CRSP US | 5,417 | $325.78K | 0.43% |
| 50 | CARIS LIFE SCIENCES INC | — | 15,855 | $319.32K | 0.42% |
1 / 6
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.